Publications
Find relevant information on health in Latin America and the Caribbean in the available reports, studies, academic articles, and reports.
Patient W.A.I.T Indicator 2023 LATAM - Argentina
Though many molecules face reimbursement restrictions and uncertainty surrounding systemic changes exists, Argentina performs better than LATAM regional averages
Patient W.A.I.T Indicator 2023 LATAM - Brazil
Though many molecules face reimbursement restrictions and uncertainty surrounding systemic changes exists, Brazil performs better than LATAM regional averages
Patient W.A.I.T Indicator 2023 LATAM - Chile
Though many molecules face reimbursement restrictions and uncertainty surrounding systemic
changes exists, Colombia performs better than LATAM regional averages
Patient W.A.I.T Indicator 2023 LATAM - Costa Rica
Though many molecules face reimbursement restrictions and uncertainty surrounding systemic changes exists, Costa Rica performs lower than LATAM regional averages
Patient W.A.I.T Indicator 2023 LATAM - Ecuador
Though many molecules face reimbursement restrictions and uncertainty surrounding systemic changes exists, Ecuador performs lower than LATAM regional averages
Patient W.A.I.T Indicator 2023 LATAM - Peru
Though many molecules face reimbursement restrictions and uncertainty surrounding systemic changes exists, Peru performs lower than LATAM regional averages
Patient W.A.I.T Indicator 2023 LATAM - Mexico
Though many molecules face reimbursement restrictions and uncertainty surrounding systemic changes exists, Mexico performs better than LATAM regional averages
Office of Health Economics: según uninforme reciente, los programas devacunación para adultos representanbeneficios socioeconómicos de hasta 19 veces superiores a la inversión inicial
Un nuevo estudio demuestra que los programas de vacunación para adultos
representan un retorno de 19 veces su inversión inicial, si se valora todo el espectro de
beneficios.
Office of Health Economics: programas devacinação para adultos proporcionambenefícios socioeconômicos até 19 vezes doinvestimento inicial, segundo novo relatório
Estudo inovador mostra que os programas de imunização para adultos retornam até 19
vezes o investimento inicial, quando todo o espectro de benefícios é valorizado